Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 74

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes

Clarke, Christine L., Graham, J. Dinny · 2012 · PLoS ONE

Abstract

The transcriptional effects of the ovarian hormone progesterone are pleiotropic, and binding to DNA of the nuclear progesterone receptor (PR), a ligand-activated transcription factor, results in diverse outcomes in a range of target tissues. To determine whether distinct patterns of genomic interaction of PR contribute to the cell specificity of the PR transcriptome, we have compared the genomic binding sites for PR in breast cancer cells and immortalized normal breast cells. PR binding was correlated with transcriptional outcome in both cell lines, with 60% of progestin-regulated genes associated with one or more PR binding regions. There was a remarkably low overlap between the PR cistromes of the two cell lines, and a similarly low overlap in transcriptional targets. A conserved PR binding element was identified in PR binding regions from both cell lines, but there were distinct patterns of enrichment of known cofactor binding motifs, with FOXA1 sites over-represented in breast cancer cell binding regions and NF1 and AP-1 motifs uniquely enriched in the immortalized normal line. Downstream analyses suggested that differential cofactor availability may generate these distinct PR cistromes, indicating that cofactor levels may modulate PR specificity. Taken together these data suggest that cell-specificity of PR binding is determined by the coordinated effects of key binding cofactors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0035859

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 58

  1. BA Lieberman, 1993, The constitution of a progesterone response element., Mol Endocrinol, 7, 515
  2. CC Nelson, 1999, Determinants of DNA sequence specificity of the androgen, progesterone, and glucocorticoid receptors: evidence for differential steroid receptor response elements., Mol Endocrinol, 13, 2090, 10.1210/mend.13.12.0396 · doi:10.1210/mend.13.12.0396 · Paper page
  3. SA Onate, 1995, Sequence and characterization of a coactivator for the steroid hormone receptor superfamily., Science, 270, 1354, 10.1126/science.270.5240.1354 · DOI · Paper page
  4. Z Liu, 2001, Sequential recruitment of steroid receptor coactivator-1 (SRC-1) and p300 enhances progesterone receptor-dependent initiation and reinitiation of transcription from chromatin., Proc Natl Acad Sci U S A, 98, 12426, 10.1073/pnas.231474798 · DOI
  5. NJ McKenna, 2002, Combinatorial control of gene expression by nuclear receptors and coregulators., Cell, 108, 465, 10.1016/S0092-8674(02)00641-4 · DOI · Paper page
  6. KM Scarpin, 2009, Progesterone action in human tissues: regulation by progesterone receptor (PR) isoform expression, nuclear positioning and coregulator expression., Nucl Recept Signal, 7, e009, 10.1621/nrs.07009 · DOI · Paper page
  7. GP Vicent, 2006, Chromatin remodeling and control of cell proliferation by progestins via cross talk of progesterone receptor with the estrogen receptors and kinase signaling pathways., Ann N Y Acad Sci, 1089, 59, 10.1196/annals.1386.025 · DOI
  8. GP Vicent, 2010, Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin., Mol Endocrinol, 24, 2088, 10.1210/me.2010-0027 · DOI
  9. GP Vicent, 2010, Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements., J Biol Chem, 285, 2622, 10.1074/jbc.M109.060848 · DOI
  10. JR Friedman, 2006, The Foxa family of transcription factors in development and metabolism., Cell Mol Life Sci, 63, 2317, 10.1007/s00018-006-6095-6 · DOI · Paper page
  11. GM Bernardo, 2010, FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis., Development, 137, 2045, 10.1242/dev.043299 · DOI · Paper page
  12. JS Carroll, 2006, Genome-wide analysis of estrogen receptor binding sites., Nat Genet, 38, 1289, 10.1038/ng1901 · DOI · Paper page
  13. A Hurtado, 2011, FOXA1 is a key determinant of estrogen receptor function and endocrine response., Nat Genet, 43, 27, 10.1038/ng.730 · DOI · Paper page
  14. Q Wang, 2007, A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth., Mol Cell, 27, 380, 10.1016/j.molcel.2007.05.041 · DOI · Paper page
  15. L Cicatiello, 2004, Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter., Mol Cell Biol, 24, 7260, 10.1128/MCB.24.16.7260-7274.2004 · DOI · Paper page
  16. PJ Kushner, 2000, Estrogen receptor pathways to AP-1., J Steroid Biochem Mol Biol, 74, 311, 10.1016/S0960-0760(00)00108-4 · DOI · Paper page
  17. L Tseng, 2003, Progesterone receptor (hPR) upregulates the fibronectin promoter activity in human decidual fibroblasts., DNA Cell Biol, 22, 633, 10.1089/104454903770238102 · DOI
  18. W Beguelin, 2010, Progesterone receptor induces ErbB-2 nuclear translocation to promote breast cancer growth via a novel transcriptional effect: ErbB-2 function as a coactivator of Stat3., Mol Cell Biol, 30, 5456, 10.1128/MCB.00012-10 · DOI
  19. EJ Faivre, 2008, Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors., Mol Endocrinol, 22, 823, 10.1210/me.2007-0437 · DOI
  20. JD Graham, 1997, Physiological action of progesterone in target tissues., Endocr Rev, 18, 502
  21. TA Longacre, 1986, A correlative morphologic study of human breast and endometrium in the menstrual cycle., Am J Surg Pathol, 10, 382, 10.1097/00000478-198606000-00003 · DOI · Paper page
  22. CI Ace, 2004, Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase., Reprod Biol Endocrinol, 2, 54, 10.1186/1477-7827-2-54 · DOI
  23. JM Borthwick, 2003, Determination of the transcript profile of human endometrium., Mol Hum Reprod, 9, 19, 10.1093/molehr/gag004 · DOI · Paper page
  24. JD Graham, 2005, Altered progesterone receptor isoform expression remodels progestin responsiveness of breast cancer cells., Mol Endocrinol, 19, 2713, 10.1210/me.2005-0126 · DOI
  25. JK Richer, 2002, Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells., J Biol Chem, 277, 5209, 10.1074/jbc.M110090200 · DOI · Paper page
  26. V Beral, 2003, Breast cancer and hormone-replacement therapy in the Million Women Study., Lancet, 362, 419, 10.1016/S0140-6736(03)14596-5 · DOI · Paper page
  27. V Beral, 2011, Breast Cancer Risk in Relation to the Interval Between Menopause and Starting Hormone Therapy., J Natl Cancer Inst, 103, 296, 10.1093/jnci/djq527 · DOI · Paper page
  28. JE Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial., JAMA, 288, 321, 10.1001/jama.288.3.321 · DOI · Paper page
  29. RT Chlebowski, 2010, Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women., JAMA, 304, 1684, 10.1001/jama.2010.1500 · DOI · Paper page
  30. JD Graham, 2009, DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast., Endocrinology, 150, 3318, 10.1210/en.2008-1630 · DOI
  31. B Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome., Genome Biol, 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
  32. A Mortazavi, 2008, Mapping and quantifying mammalian transcriptomes by RNA-Seq., Nat Methods, 5, 621, 10.1038/nmeth.1226 · DOI · Paper page
  33. AV Roschke, 2003, Karyotypic complexity of the NCI-60 drug-screening panel., Cancer Res, 63, 8634
  34. Q Tang, 2011, A comprehensive view of nuclear receptor cancer cistromes., Cancer Res, 71, 6940, 10.1158/0008-5472.CAN-11-2091 · DOI
  35. D Wang, 2011, Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA., Nature, 474, 390, 10.1038/nature10006 · DOI · Paper page
  36. R Joseph, 2010, Integrative model of genomic factors for determining binding site selection by estrogen receptor-alpha., Mol Syst Biol, 6, 456, 10.1038/msb.2010.109 · DOI
  37. R Bravieri, 1997, Different DNA contact schemes are used by two winged helix proteins to recognize a DNA binding sequence., Nucleic Acids Res, 25, 2888, 10.1093/nar/25.14.2888 · DOI
  38. LA Cirillo, 2007, Specific interactions of the wing domains of FOXA1 transcription factor with DNA., J Mol Biol, 366, 720, 10.1016/j.jmb.2006.11.087 · DOI
  39. S Pierrou, 1994, Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending., EMBO J, 13, 5002, 10.1002/j.1460-2075.1994.tb06827.x · DOI · Paper page
  40. WJ Welboren, 2009, ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands., EMBO J, 28, 1418, 10.1038/emboj.2009.88 · DOI · Paper page
  41. KL Macquarrie, 2011, Genome-wide transcription factor binding: beyond direct target regulation., Trends Genetics, 27, 141, 10.1016/j.tig.2011.01.001 · DOI · Paper page
  42. SA Krum, 2008, Unique ERalpha cistromes control cell type-specific gene regulation., Molecular Endocrinology, 22, 2393, 10.1210/me.2008-0100 · DOI
  43. AY So, 2007, Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor., PLoS Genet, 3, e94, 10.1371/journal.pgen.0030094 · DOI · Paper page
  44. EC Bolton, 2007, Cell- and gene-specific regulation of primary target genes by the androgen receptor., Genes Dev, 21, 2005, 10.1101/gad.1564207 · DOI · Paper page
  45. P Yin, 2012, Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells., PLoS One, 7, e29021, 10.1371/journal.pone.0029021 · DOI
  46. GV Rayasam, 2005, Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro., Mol Cell Biol, 25, 2406, 10.1128/MCB.25.6.2406-2418.2005 · DOI
  47. S Belikov, 2009, FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter., Mol Cell Biol, 29, 5413, 10.1128/MCB.00368-09 · DOI
  48. I Garcia-Bassets, 2007, Histone methylation-dpendent mechanisms impose ligand dependency for gene activation by nuclear receptors., Cell, 128, 505, 10.1016/j.cell.2006.12.038 · DOI · Paper page
  49. E Metzger, 2005, LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription., Nature, 437, 436, 10.1038/nature04020 · DOI · Paper page
  50. J Murtagh, 2003, The Nuclear Factor I (NFI) gene family in mammary gland development and function., J Mammary Gland Biol Neoplasia, 8, 241, 10.1023/A:1025909109843 · DOI
  51. CH Streuli, 1995, Stat5 as a target for regulation by extracellular matrix., J Biol Chem, 270, 21639, 10.1074/jbc.270.37.21639 · DOI
  52. CL Clarke, 1987, Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques., Endocrinology, 121, 1123, 10.1210/endo-121-3-1123 · DOI
  53. H Ji, 2008, An integrated software system for analyzing ChIP-chip and ChIP-seq data., Nat Biotechnol, 26, 1293, 10.1038/nbt.1505 · DOI · Paper page
  54. S Heinz, 2010, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities., Mol Cell, 38, 576, 10.1016/j.molcel.2010.05.004 · DOI · Paper page
  55. TL Bailey, 2006, MEME: discovering and analyzing DNA and protein sequence motifs., Nucleic Acids Res, 34, W369, 10.1093/nar/gkl198 · DOI · Paper page
  56. TL Bailey, 2010, The value of position-specific priors in motif discovery using MEME., BMC Bioinformatics, 11, 179, 10.1186/1471-2105-11-179 · DOI
  57. M Reich, 2006, GenePattern 2.0., Nat Genet, 38, 500, 10.1038/ng0506-500 · DOI · Paper page
  58. JD Graham, 1995, Characterization of progesterone receptor A and B expression in human breast cancer., Cancer Res, 55, 5063

Cited by

See all 74

Metadata

Authors
Clarke, C. L., & Graham, J. D.
Venue
PLoS ONE
Published
2012-04-24
Volume
7
Issue
4
Pages
e35859
ISSN
1932-6203
Cited by
74
References
7
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes. https://app.cochat.ai/papers/10.1371/journal.pone.0035859
The paper
Clarke, C. L., & Graham, J. D. (2012). Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes. PLoS ONE. https://doi.org/10.1371/journal.pone.0035859

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.